SMARCA4 and pulmonary arterial hypertension: BRG1 can potentially activate the transcription of endothelin (ET-1), an endothelial derived vasoconstrictor, promote hypoxia-induced pulmonary hypertension (Yang et al., 2013) and Ang II induced cardiac hypertrophy (Weng et al., 2015).